Current Drug Discovery Technologies
Volume 16, 4 Issues, 2019
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
ISSN: 1875-6220 (Online)
ISSN: 1570-1638 (Print)
This journal supports open access
Most Cited Articles
Insight into the Structural Requirements of Theophylline-Based Aldehyde Dehydrogenase lAl (ALDHlAl) Inhibitors Through Multi-QSAR Modeling and Molecular Docking Approaches
, 2016; 13(2): 84-100.Sk. Abdul Amin, Nilanjan Adhikari, Shovanlal Gayen and Tarun Jha
DOI: 10.2174/1570163813666160429115628
Designing Potential Antitrypanosomal Thiazol-2-ethylamines through Predictive Regression Based and Classification Based QSAR Analyses
, 2017; 14(1): 39-52.Sk. Abdul Amin, Nilanjan Adhikari, Sonam Bhargava, Tarun Jha and Shovanlal Gayen
DOI: 10.2174/1570163813666161117144137
Anti-Aging Property of G2013 Molecule as a Novel Immunosuppressive Agent on Enzymatic and Non-Enzymatic Oxidative Stress Determinants in Rat Model
, 2016; 13(1): 25-33.Abbas Mirshafiey, Soma Hosseini, Sanaz Afraei, Noshin Rastkari, Farzaneh T. Zavareh and Gholamreza Azizi
DOI: 10.2174/1570163813666160224123851
Peptides for Anti-Ebolavirus Vaccines
, 2016; 13(4): 225-231.Darja Kanduc
DOI: 10.2174/1570163813666160902131603
Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma
, 2016; 13(2): 68-76.Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall and John Abisheganaden
DOI: 10.2174/1570163813666160524142846
Potential Crossreactivity of Human Immune Responses Against HCMV Glycoprotein B
, 2016; 13(1): 16-24.Guglielmo Lucchese and Darja Kanduc
DOI: 10.2174/1568009616666160129100621
The Potent Inhibitory Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID with Immunosuppressive Property on Anti-Cyclic Citrullinated Peptide Antibodies, Rheumatoid Factor and Anti-dsDNA Antibodies in Patients with Rheumatoid Arthritis
, 2017; 14(3): 206-214.Hossein Ahmadi, Ahmad R. Jamshidi, Mahdi Mahmoudi, Salvatore Cuzzocrea, Mohammad Javad Fattahi, Anis Barati, Bernd H. A. Rehm, Hidenori Matsuo and Abbas Mirshafiey*
DOI: 10.2174/1570163814666170321113059
Phytochemistry and Phytotherapeutic Aspects of Elaeagnus angustifolia L.
, 2016; 13(4): 199-210.Farid Niknam, Amir Azadi, Alireza Barzegar, Pouya Faridi, Nader Tanideh and Mohammad M. Zarshenas
DOI: 10.2174/1570163813666160905115325
Quantitative Structure-Cytotoxic Activity Relationship 1-(Benzoyloxy)urea and Its Derivative
, 2016; 13(2): 101-108.Suko Hardjono, Siswandono Siswodihardjo, Purwanto Pramono and Win Darmanto
DOI: 10.2174/1570163813666160525112327
Possible Anticancer Mechanisms of Some Costus speciosus Active Ingredients Concerning Drug Discovery
, 2016; 13(3): 123-143.Ali H. El-Far, Faried A. Badria and Hazem M. Shaheen
DOI: 10.2174/1570163813666160802154403
  |
Editor-in-Chief
Vladimir P. Torchilin
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115
USA
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Discovery Technologies Journal was launched in 2004. Dr. Vladimir P. Torchilin serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.81
New eBook
 |
Frontiers in Clinical Drug Research – Alzheimer DisordersYou can view the contents of this eBook [here] or purchase it [here]. |
Webmaster Contact: info@benthamscience.net